Implications for dosing frequency Despite the short serum half-life, daily (rather than multiple-times-daily) dosing has been shown adequate in most BPC-157 rodent studies
The primary antibodies used are as follows: P53 (Proteintech, 60283-2-Ig), pSer46-P53 (CST, 2521), FOXO4 (Proteintech, 21535-1-AP), Ki-67 (D3B5) Rabbit mAb (Alexa Fluor 647 Conjugate) (CST, 12075), P21 (CST, 14074), -H2AX (Abcam, ab2254)
Valproic acid advantages: Phenobarbital has a very long half-life, which makes down-titration challenging if excessive somnolence occurs
To investigate glucose levels and GLUD1 regulation, we established glucose concentration gradients and observed that high glucose destabilized GLUD1 by inhibiting the PI3K/AKT pathway, whereas glucose downregulation, achieved by insulin or metformin treatment, promoted GLUD1 protein accumulation
However, results can vary from person to person, and it is crucial to consult with a healthcare professional before beginning any new supplement regimen